 Proof of the causal link between HPV and cervical cancer has allowed for the recent development of HPV-based screening tests, which detect HPV types considered high-risk. These tests have important advantages over the Pap as a screening test: high sensitivity over 902 and high negative predictive value3, allowing for a reduction in screening frequency as well as for the identification of HPV positive women who, even without presenting a precancerous lesion, constitute a high-risk group that requires special follow-up within the health system. Very importantly, through self-collection, HPV-testing can reduce barriers to screening and increase coverage.4 The method is highly accurate5,6, and is acceptable for women in different countries.7-10 